Michael Nauck discusses incretin-based drugs and pancreatitis risk.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

The Lancet Diabetes & Endocrinology: November 14, 2013

Editors at The Lancet Diabetes &amp; Endocrinology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.&nbsp;

 A monthly audio companion to the journal, this podcast covers a broad range of topics, from thyroid cancer to childhood obesity, the mechanisms of ageing to erectile dysfunction, and more.

Education

Training

Language Courses

Higher Education

K-12

Educational Technology

Medicine

Science & Medicine

Science

Health & Fitness

Life Sciences

Márta Korbonits talks with The Lancet Diabetes & Endocrinology about mechanisms of ageing: growth hormone, dietary restriction, and metformin.Read the full article:Mechanisms of ageing: growth hormone, dietary restriction, and metforminContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Márta Korbonits on mechanisms of ageing

Mirjam Christ-Crain and Cihan Atila talk with The Lancet Diabetes & Endocrinology about central diabetes insipidus from a patient's perspective. Read the full article:Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based surveyContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelan...

Mirjam Christ-Crain and Cihan Atila on the patient's perspective of central diabetes insipidus

Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.Read the full article:Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngiomaContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://you...

Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Rossella Nappi talks with The Lancet Diabetes & Endocrinology about cardiometabolic changes that occur during the menopausal transition and implications for women’s health.Read the full Series:MenopauseContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Rossella Nappi on menopause as a turning point for women's health

Louise Baur talks with The Lancet Diabetes & Endocrinology about the prevalence and causes of child and adolescent obesity, and the need for personalised treatment approaches.Read the full article:Obesity in children and adolescents: epidemiology, causes, assessment, and managementContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps...

The Lancet Diabetes & Endocrinology: November 14, 2013

Download our free app to listen on your phone